|
MAGEF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.71729999995674E-06 |
| Normal-vs-Stage3 |
1.18793863634892E-14 |
| Normal-vs-Stage4 |
1.69342317946075E-12 |
| Stage1-vs-Stage2 |
3.440600E-01 |
| Stage1-vs-Stage3 |
8.225200E-01 |
| Stage1-vs-Stage4 |
3.260800E-01 |
| Stage2-vs-Stage3 |
4.788800E-01 |
| Stage2-vs-Stage4 |
1.697820E-01 |
| Stage3-vs-Stage4 |
3.308400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
2.28440000249464E-08 |
| Normal-vs-Asian |
1.092903545441E-11 |
| Caucasian-vs-AfricanAmerican |
1.009170E-01 |
| Caucasian-vs-Asian |
2.230800E-01 |
| AfricanAmerican-vs-Asian |
5.271800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
8.233200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.6286971771251E-11 |
| Normal-vs-Age(81-100Yrs) |
7.496300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.714600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.506600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.546400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.981440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.966600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.228800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.503600E-01 |
| Classical-VS-Follicular |
5.42650000046052E-07 |
| Classical-VS-Other |
7.878200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.484440E-02 |
| Tall-VS-Other |
7.693400E-01 |
| Tall-VS-Normal |
2.69259999852167E-08 |
| Follicular-VS-Other |
1.771170E-01 |
| Follicular-VS-Normal |
1.023350E-04 |
| Other-VS-Normal |
3.321900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62503344114384E-12 |
| Normal-vs-N1 |
5.04052355410067E-12 |
| N0-vs-N1 |
4.626600E-01 |
|
|
